Bruker (BRKR) reported Q3 non-GAAP earnings Tuesday of $0.60 per diluted share, down from $0.74 a year earlier.
Analysts polled by Capital IQ expected $0.60 per share.
Revenue in the quarter ended Sept. 30 was $864.4 million, up from $742.8 million a year earlier.
Analysts surveyed by Capital IQ expected $866.1 million.
The company lowered its outlook for 2024 non-GAAP EPS to $2.36 to $2.41, from $2.59 to $2.64 previously. Analysts surveyed by Capital IQ expect $2.60.
Bruker expects 2024 revenue of $3.34 billion to $3.37 billion, compared with $3.38 billion and $3.44 billion previously. Analysts polled by Capital IQ expect $3.40 billion.
Bruker shares fell by more than 6% in premarket trading.
Price: 55.99, Change: -3.36, Percent Change: -5.66
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。